Information updates

ASCIA 2022 Conference Health and Safety Measures

The ASCIA 2022 Conference is being held as a hybrid event, which enables in-person or virtual attendance.  

ASCIA and the Melbourne Convention and Exhibition Centre (MCEC) will have measures in place for in-person attendance, to ensure that the ASCIA 2022 Conference will be held in the safest possible way, to protect the health of everyone involved.

These measures include:

  • Physical distanced seating arrangements
  • Limited delegate numbers for each meeting room
  • Mask wearing in the conference
  • Rapid antigen testing requested prior to attending conference
  • Eco box catering instead of lunch buffets
  • Sanitisation stations throughout the venue

To further minimise risk, the Welcome Function will not proceed this year, as this type of large cocktail style function is deemed to be a high risk for spreading infections. Instead we will ensure that all other catering is of the highest quality, with a range of premium lunch and break menus.

Dinners will still proceed on the Wednesday evening (Trainee and Supervisor Dinner) and Thursday evening (Gala Dinner) and these events will include health and safety measures.  

ASCIA recommends:

  • Travel insurance for all delegates who are travelling to attend in-person.
  • Virtual registration for people who are unwell or hesitant to attend in-person due to serious health concerns.

DO NOT ATTEND THE ASCIA 2022 CONFERENCE IF YOU HAVE ANY COVID-19, INFLUENZA OR COLD SYMPTOMS. 

If anyone experiences COVID-19, influenza or cold symptoms whilst attending the ASCIA 2022 Conference in-person, they should leave the venue immediately, isolate and test. If this isn't possible, venue staff can escort the person to an isolation room and provide a rapid antigen test for immediate assessment.

For all other first aid incidents first aid rooms are located on the Ground Floor of the MCEC. 

The MCEC venuesafe plan is available at https://mcec.com.au/venuesafe/visitor 

 

This news item was issued on 27 July 2022 by Jill Smith, CEO of the Australasian Society of Clinical Immunology and Allergy (ASCIA). ASCIA is the peak professional body for clinical immunology and allergy in Australia and New Zealand.   

 

Mod ASCIA Member
Donate to AIFA
go to NAS website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.